Navigation Links
KV Pharmaceutical Divests ANDA for Generic Version of Duac(R)
Date:9/21/2009

ST. LOUIS, Sept. 21 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) today announced the sale to Perrigo Company (Nasdaq: PRGO) of KV's first-to-file Paragraph IV Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for a generic equivalent version of GlaxoSmithKline's Duac(R) gel.

Under the terms of the transaction, KV will receive $14 million from Perrigo at closing and an additional, $2 million milestone payment upon the completion of a successful technical transfer. Duac(R) (clindamycin, 1%-benzoyl peroxide, 5%) is indicated for the topical treatment of mild to moderate acne vulgaris.

About KV Pharmaceutical Company

KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets, and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products. The Company markets its technology distinguished products through ETHEX Corporation, a subsidiary that competes with branded products, and Ther-Rx Corporation, the company's branded drug subsidiary.

For further information about KV Pharmaceutical Company, please visit the Company's corporate Web site at www.kvpharmaceutical.com.

Cautionary Note Regarding Forward-looking Statements

The information in this press release may contain various forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 ("PSLRA") and which may be based on or include assumptions concerning the operations, future results and prospects of the Company. Such statements may be identified by the use of words like "plan," "expect," "aim," "b
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Vestara and MedClean Technologies Announce Co-Marketing Partnership to Expand Innovative Solution for Pharmaceutical Waste Management
2. VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ
3. Valeant Pharmaceuticals to Present at the UBS Global Life Sciences Conference
4. Siperian to Host Webinar With Panel of Pharmaceutical Experts
5. Glaxo Official Memo Urged Scientists to Withhold Information About Paxils Risks, Trial Hears; Pharmaceutical Industry Today Offers Complete News Coverage
6. Keryx Biopharmaceuticals Receives Orphan-Drug Designation for KRX-0401 (Perifosine) for the Treatment of Multiple Myeloma
7. AUDIO from Medialink and Solvay Pharmaceuticals: New High Five Program Addresses Energy Levels of Overweight Men
8. KV Pharmaceutical Receives Stockholder Action by Written Consent
9. Caraco Pharmaceutical Laboratories, Ltd. Announces Appointment of F. Folsom Bell to Board of Directors
10. UK's Newcastle University Introduces First-Ever Biopharmaceutical Engineering Doctorate Program
11. Sun Pharmaceutical Announces Expiration of HSR Act Waiting Period for Taro Tender Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... On August 30, 2014, Harper’s Bazaar Magazine ... Should Wash Your Face .” According to the ... breathes air considered polluted by the World Health Organization. ... skin’s pores destroying its natural oils. These oils act ... may cause cell damage, redness, aging skin , ...
(Date:9/2/2014)... with early-stage breast cancer in California, the percentage undergoing ... although this procedure was not associated with a lower ... to a study in the September 3 issue of ... for the removal of one breast was associated with ... examined in the study. , Randomized trials have demonstrated ...
(Date:9/2/2014)... emergency department within a few days of discharge do so ... lost trust in other parts of the health care system, ... in Annals of Emergency Medicine ( "Return Visits ... , "When asked why they did not follow up as ... severe to wait until their scheduled appointment or being instructed ...
(Date:9/2/2014)... Operators in the Community Services industry ... care and counsel for those in need. In 2014-15, ... derive $39.4 billion in revenue, which includes a combination ... five years through 2014-15, the subdivision is forecast to ... of 4.1% in 2014-15. , As the population ages ...
(Date:9/2/2014)... Steven Reinberg ... News) -- Stimulant medications -- such as Adderall, Ritalin ... in children, won,t stunt their growth, a new study ... height as adults," said study researcher Dr. Slavica Katusic, ... in Rochester, Minn. Katusic noted that results of ...
Breaking Medicine News(10 mins):Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3Health News:Discharged patients return to the ER because 'better safe than sorry' 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:ADHD Medications Won't Stunt Kids' Growth, Study Finds 2Health News:ADHD Medications Won't Stunt Kids' Growth, Study Finds 3
... with higher blood levels of chemicals used in the ... likely to have elevated total and LDL cholesterol levels, ... Archives of Pediatrics & Adolescent Medicine , one ... the man-made compounds known as perfluoroalkyl acidsincluding perfluorooctanoic acid ...
... one-fifth of fathers in the United Kingdom appear to experience ... year of age, with the highest rates in the first ... that will appear in the November print issue of ... JAMA/Archives journals. "Depression in parents is associated with adverse ...
... MONDAY, Sept. 6 (HealthDay News) -- Money can help buy ... a year, new research shows. While happiness increases along ... earning more money has no effect on day-to-day contentment, according ... give up trying to get that promotion. While making more ...
... , FRIDAY, Sept. 3 (HealthDay News) -- Feeding obese mice ... a new study finds. Fish oil supplements that contain ... most popular dietary supplements in the United States. While omega-3 ... they work hasn,t been well understood, said study co-author Saswata ...
... CAMBRIDGE, Mass. - Phosphorus, a mineral element found in ... pesticides, detergents and other industrial and household chemicals. Once ... products is hazardous and expensive, and chemists have been ... chemistry professor Christopher Cummins and one of his graduate ...
... Amanda Gardner HealthDay Reporter , FRIDAY, Sept. 3 ... in flophouses, theaters and high-end offices, bedbugs are popping up ... more places than just your bed. According ... 95 percent of U.S. pest management companies surveyed said they ...
Cached Medicine News:Health News:Compounds in non-stick cookware may be associated with elevated cholesterol in children and teens 2Health News:Parents at highest risk for depression in the first year after child's birth 2Health News:After $75,000, Money Can't Buy Day-to-Day Happiness 2Health News:After $75,000, Money Can't Buy Day-to-Day Happiness 3Health News: Mouse Study May Help Explain Fish Oil's Benefits 2Health News: Mouse Study May Help Explain Fish Oil's Benefits 3Health News:MIT moves toward greener chemistry 2Health News:MIT moves toward greener chemistry 3Health News:Bedbug Nation: Critters Make a Comeback 2Health News:Bedbug Nation: Critters Make a Comeback 3Health News:Bedbug Nation: Critters Make a Comeback 4
(Date:9/2/2014)... , España, September 2, 2014 ... global de fibrilación atrial muestran agentes antitrombóticos no ... -- Las presentaciones de GARFIELD-AF ... sobre el tratamiento y los resultados de pacientes ... clínica diaria --    Los datos ...
(Date:9/2/2014)... -- According to the new market research ... by Material (Metal, Glass, Plastic), by Application [GC, LC ... published by MarketsandMarkets, the Chiral Chromatography Columns Market was ... grow at a CAGR of 5.2% from 2013 to ... 90 market data tables and 15 figures spread through ...
(Date:9/2/2014)... 2014 Particle Sciences, the leading CDMO for ... development and manufacturing capabilities with the addition of a ... Particle Sciences, Associate Director Clinical Production, "The company has ... square footage, equipment and staff across the board, all ... has over 6000ft 2 of operating cleanroom and ...
Breaking Medicine Technology:Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 2Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 3Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 4Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 5Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 6Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 7Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 8Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 9Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 10Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 11Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources 2
... Sept. 2 NewCardio (OTC Bulletin Board: NWCI ... Renz, Jr., NewCardio,s President and CEO, purchased 128,000 shares during ... weeks following the Company,s filing of its SEC Form 10-Q ... 2010. "As discussed on our August 12, ...
... SKILLMAN, N.J., Sept. 2 ConvaTec, a world-leading developer ... hospital care, announced today the introduction of a new, ... with Strengthening Fibers, now available in the U.S. and ... highly exuding chronic and acute wounds. The new dressing, ...
Cached Medicine Technology:NewCardio CEO Increases Equity Position 2NewCardio CEO Increases Equity Position 3NewCardio CEO Increases Equity Position 4ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing 2ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing 3ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: